Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monosodium urate (MSU) crystals increase gout associated coronary heart disease (CHD) risk through the activation of NLRP3 inflammasome.

Literature DB >> 22726397

Monosodium urate (MSU) crystals increase gout associated coronary heart disease (CHD) risk through the activation of NLRP3 inflammasome.

Jia He, Yang Yang, Dao-Quan Peng.

Abstract

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 2012 PMID： 22726397 DOI： 10.1016/j.ijcard.2012.05.083

Source DB: PubMed Journal: Int J Cardiol ISSN： 0167-5273 Impact factor: 4.164

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Anti-nociceptive and anti-edematogenic effects of glibenclamide in a model of acute gouty attack in rats.

Authors: Rosane M S dos Santos; Sara M Oliveira; Cássia R Silva; Carin Hoffmeister; Juliano Ferreira; Jamil Assreuy
Journal: Inflamm Res Date: 2013-03-30 Impact factor: 4.575

2. Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials.

Authors: Tunlanut Sapankaew; Kunlawat Thadanipon; Narisa Ruenroengbun; Kamolpat Chaiyakittisopon; Atiporn Ingsathit; Pawin Numthavaj; Nathorn Chaiyakunapruk; Gareth McKay; John Attia; Ammarin Thakkinstian
Journal: BMC Nephrol Date: 2022-06-23 Impact factor: 2.585

3. NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis.

Authors: Zhaofei Wan; Yan Fan; Xiaojun Liu; Jiahong Xue; Zhenhua Han; Canzhan Zhu; Xinhong Wang
Journal: Diabetes Metab Syndr Obes Date: 2019-09-20 Impact factor: 3.168

Review 4. Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases.

Authors: Na An; Yonghong Gao; Zeyu Si; Hanlai Zhang; Liqin Wang; Chao Tian; Mengchen Yuan; Xinyu Yang; Xinye Li; Hongcai Shang; Xingjiang Xiong; Yanwei Xing
Journal: Front Immunol Date: 2019-07-10 Impact factor: 7.561

5. Angiotensin-II activates vascular inflammasome and induces vascular damage.

Authors: Stefany B Cau; Ariane Bruder-Nascimento; Marcondes B Silva; Fernanda N Z Ramalho; Fabiola Mestriner; Rheure Alves-Lopes; Nathanne Ferreira; Rita C Tostes; Thiago Bruder-Nascimento
Journal: Vascul Pharmacol Date: 2021-06-09 Impact factor: 5.738

Monosodium urate (MSU) crystals increase gout associated coronary heart disease (CHD) risk through the activation of NLRP3 inflammasome.

1. Anti-nociceptive and anti-edematogenic effects of glibenclamide in a model of acute gouty attack in rats.

2. Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials.

3. NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis.

Review 4. Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases.

5. Angiotensin-II activates vascular inflammasome and induces vascular damage.

6. Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims.

Review 7. NLRP3 Inflammasome and Its Central Role in the Cardiovascular Diseases.

Review 8. The Inflammasome in Times of COVID-19.